BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16360214)

  • 1. Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis.
    Sionov E; Mendlovic S; Segal E
    J Infect; 2006 Aug; 53(2):131-9. PubMed ID: 16360214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF.
    Sionov E; Mendlovic S; Segal E
    J Antimicrob Chemother; 2005 Sep; 56(3):594-7. PubMed ID: 16006446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis.
    van Vianen W; de Marie S; ten Kate MT; Mathot RA; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2006 Apr; 57(4):732-40. PubMed ID: 16464895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Abelcet and caspofungin, alone or in combination, against CNS aspergillosis in a murine model.
    Imai J; Singh G; Fernandez B; Clemons KV; Stevens DA
    J Antimicrob Chemother; 2005 Jul; 56(1):166-71. PubMed ID: 15917284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis.
    Clemons KV; Stevens DA
    Med Mycol; 2006 Feb; 44(1):69-73. PubMed ID: 16805095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of murine systemic aspergillosis with polyene-intralipid admixtures.
    Sionov E; Segal E
    Med Mycol; 2004 Feb; 42(1):73-80. PubMed ID: 14982116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
    Clemons KV; Espiritu M; Parmar R; Stevens DA
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4867-75. PubMed ID: 16304147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.
    Wasan KM; Sivak O; Rosland M; Risovic V; Bartlett K
    J Pharm Sci; 2007 Jul; 96(7):1737-47. PubMed ID: 17080414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
    Chandrasekar PH; Cutright JL; Manavathu EK
    Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
    Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
    Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate.
    Bowman JC; Abruzzo GK; Anderson JW; Flattery AM; Gill CJ; Pikounis VB; Schmatz DM; Liberator PA; Douglas CM
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3474-81. PubMed ID: 11709327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.
    Nagasaki Y; Eriguchi Y; Uchida Y; Miyake N; Maehara Y; Kadowaki M; Harada M; Akashi K; Shimono N
    J Antimicrob Chemother; 2009 Aug; 64(2):379-82. PubMed ID: 19465436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis.
    Sivak O; Bartlett K; Risovic V; Choo E; Marra F; Batty DS; Wasan KM
    J Pharm Sci; 2004 Jun; 93(6):1382-9. PubMed ID: 15124198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.
    Warn PA; Sharp A; Morrissey G; Denning DW
    Int J Antimicrob Agents; 2010 Feb; 35(2):146-51. PubMed ID: 20015618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin.
    Graybill JR; Bocanegra R; Gonzalez GM; Najvar LK
    J Antimicrob Chemother; 2003 Oct; 52(4):656-62. PubMed ID: 12972452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
    Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease.
    Dennis CG; Greco WR; Brun Y; Youn R; Slocum HK; Bernacki RJ; Lewis R; Wiederhold N; Holland SM; Petraitiene R; Walsh TJ; Segal BH
    Antimicrob Agents Chemother; 2006 Feb; 50(2):422-7. PubMed ID: 16436692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia.
    Petraitiene R; Petraitis V; Groll AH; Sein T; Schaufele RL; Francesconi A; Bacher J; Avila NA; Walsh TJ
    Antimicrob Agents Chemother; 2002 Jan; 46(1):12-23. PubMed ID: 11751105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation.
    Kriván G; Sinkó J; Nagy IZ; Goda V; Reményi P; Bátai A; Lueff S; Kapás B; Réti M; Tremmel A; Masszi T
    Acta Biomed; 2006; 77 Suppl 2():17-21. PubMed ID: 16918062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.